🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/10/1991 | 20,61 | 20,61 | 20,28 | 20,36 | -1,16% | 1,64% | 3.038.990 |
| 04/10/1991 | 20,61 | 20,69 | 20,54 | 20,59 | -0,19% | 0,77% | 2.490.677 |
| 03/10/1991 | 20,63 | 20,71 | 20,63 | 20,63 | -0,48% | 0,39% | 2.049.259 |
| 02/10/1991 | 20,83 | 20,89 | 20,61 | 20,73 | -0,57% | 1,34% | 2.312.098 |
| 01/10/1991 | 20,77 | 20,89 | 20,73 | 20,85 | +0,77% | 0,77% | 2.518.973 |
| 30/09/1991 | 20,48 | 20,75 | 20,42 | 20,69 | +1,07% | 1,65% | 2.535.950 |
| 27/09/1991 | 20,67 | 20,79 | 20,44 | 20,48 | -0,96% | 1,73% | 2.532.806 |
| 26/09/1991 | 20,59 | 20,77 | 20,48 | 20,67 | +0,10% | 1,45% | 2.542.867 |
| 25/09/1991 | 20,85 | 20,87 | 20,59 | 20,65 | -1,05% | 1,33% | 2.225.952 |
| 24/09/1991 | 20,73 | 20,87 | 20,46 | 20,87 | +0,67% | 2,01% | 4.275.211 |
| 23/09/1991 | 21,03 | 21,09 | 20,71 | 20,73 | -1,60% | 1,80% | 2.763.576 |
| 20/09/1991 | 21,07 | 21,19 | 20,97 | 21,07 | +0,57% | 1,04% | 5.996.237 |
| 19/09/1991 | 20,87 | 21,13 | 20,87 | 20,95 | +0,19% | 1,24% | 2.246.702 |
| 18/09/1991 | 20,83 | 20,95 | 20,79 | 20,91 | -0,19% | 0,76% | 2.130.374 |
| 17/09/1991 | 20,59 | 20,95 | 20,57 | 20,95 | +1,64% | 1,83% | 2.889.336 |
| 16/09/1991 | 20,46 | 20,65 | 20,38 | 20,61 | +0,68% | 1,36% | 3.122.621 |
| 13/09/1991 | 20,79 | 20,79 | 20,44 | 20,48 | -1,53% | 1,72% | 4.158.883 |
| 12/09/1991 | 20,81 | 20,81 | 20,61 | 20,79 | +0,38% | 0,96% | 2.837.774 |
| 11/09/1991 | 20,52 | 20,79 | 20,48 | 20,71 | +1,07% | 1,55% | 2.927.693 |
| 10/09/1991 | 20,67 | 20,71 | 20,40 | 20,50 | -0,48% | 1,54% | 3.755.194 |
| 09/09/1991 | 20,24 | 20,63 | 20,24 | 20,59 | +1,87% | 1,96% | 2.740.310 |
| 06/09/1991 | 20,14 | 20,28 | 20,00 | 20,22 | +0,69% | 1,38% | 2.248.589 |
| 05/09/1991 | 20,06 | 20,20 | 20,04 | 20,08 | +0,40% | 0,79% | 3.296.170 |
| 04/09/1991 | 20,12 | 20,16 | 19,94 | 20,00 | -0,59% | 1,09% | 2.542.238 |
| 03/09/1991 | 20,10 | 20,30 | 20,10 | 20,12 | -0,30% | 0,99% | 2.906.942 |
| 30/08/1991 | 20,34 | 20,40 | 20,12 | 20,18 | -1,36% | 1,37% | 2.042.342 |
| 29/08/1991 | 20,36 | 20,46 | 20,24 | 20,46 | +0,59% | 1,07% | 2.791.243 |
| 28/08/1991 | 19,92 | 20,34 | 19,88 | 20,34 | +2,20% | 2,30% | 2.986.171 |
| 27/08/1991 | 20,00 | 20,00 | 19,78 | 19,90 | -0,40% | 1,09% | 2.705.098 |
| 26/08/1991 | 20,02 | 20,08 | 19,94 | 19,98 | -0,20% | 0,69% | 1.836.725 |